Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Google/Alphabet (NASDAQ: GOOGL) cloud productivity suite with 9M+ paying businesses and Gemini AI; Gmail, Docs, Meet, and Drive competing with Microsoft 365 and Copilot for enterprise productivity platform.
Google Workspace is Alphabet's (NASDAQ: GOOGL) cloud productivity suite providing Gmail, Google Drive, Docs, Sheets, Slides, Meet, Chat, Calendar, and admin management tools for businesses, schools, and organizations — competing with Microsoft 365 for enterprise productivity platform dominance. Google Workspace serves 9+ million paying businesses and 3 billion users of Gmail globally across subscription tiers from Business Starter ($6/user/month) to Enterprise, generating an estimated $12+ billion in annual recurring revenue as one of Google Cloud's most significant recurring revenue streams.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.